Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
NCT02263027 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2016-01-14
Summary
This study will recruit 35 healthcare workers who had systemic reactions to influenza vaccine the last 2 times they were vaccinated, to ask whether influenza vaccine is indeed associated with systemic reactions in these workers.
Conditions
Interventions
- BIOLOGICAL
-
Vaccine
Licensed trivalent inactivated influenza vaccine
Sponsors & Collaborators
-
Mount Sinai Hospital, Canada
lead OTHER
Principal Investigators
-
Allison J McGeer, MD · MOUNT SINAI HOSPITAL
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Immunogenicity Study of the Influenza Vaccine in Adults
NCT00258934 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
NCT00522067 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
NCT02269852 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines
NCT00776438 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study
NCT01522248 ·Status: COMPLETED ·Phase: NA
-
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
NCT02037282 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults
NCT02148328 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China
NCT02269007 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IV Clinical Trial of an Influenza Split Vaccine Anflu
NCT00556062 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
NCT03581903 ·Status: COMPLETED ·Phase: PHASE1
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
NCT00560066 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine
NCT00677820 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects
NCT02256488 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine
NCT01465035 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers
NCT01010737 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine
NCT02585700 ·Status: COMPLETED ·Phase: PHASE1